Marcos Lutz - Corteva Independent Director
| CTVA Stock | USD 55.18 0.02 0.04% |
Insider
Marcos Lutz is Independent Director of Corteva since 2019.
| Age | 51 |
| Tenure | 5 years |
| Address | 9330 Zionsville Road, Indianapolis, IN, United States, 46268 |
| Phone | 833 267 8382 |
| Web | https://www.corteva.com |
Corteva Management Efficiency
The company has return on total asset (ROA) of 0.0293 % which means that it generated a profit of $0.0293 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.037 %, meaning that it created $0.037 on every $100 dollars invested by stockholders. Corteva's management efficiency ratios could be used to measure how well Corteva manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.03. The current year's Return On Capital Employed is expected to grow to 0.04. At present, Corteva's Return On Tangible Assets are projected to increase slightly based on the last few years of reporting. The current year's Intangibles To Total Assets is expected to grow to 0.54, whereas Total Assets are forecasted to decline to about 36.2 B.Similar Executives
| Showing other executives | INSIDER Age | ||
| Robert Gilbane | American Vanguard | 73 | |
| Charlotte Hebebrand | Nutrien | N/A | |
| Amir Meshulam | ICL Israel Chemicals | 44 | |
| Lilach GevaHarel | ICL Israel Chemicals | 44 | |
| Alex Wagner | Intrepid Potash | 44 | |
| Gadi Lesin | ICL Israel Chemicals | 53 | |
| Elad Aharonson | ICL Israel Chemicals | 50 | |
| Eli Amon | ICL Israel Chemicals | 54 | |
| Deborah DeHaas | CF Industries Holdings | 61 | |
| Mary Mcbride | Intrepid Potash | 65 | |
| Tzipi OzerArmon | ICL Israel Chemicals | 54 | |
| Timothy Esq | American Vanguard | 64 | |
| Michael McGrane | CF Industries Holdings | 50 | |
| Candace Laing | Nutrien | N/A | |
| Julie Freigang | CF Industries Holdings | 56 | |
| Thaisa Hugenneyer | FMC Corporation | N/A | |
| Dafna Gruber | ICL Israel Chemicals | 55 | |
| Floris Bielders | The Mosaic | N/A | |
| John Richardson | Intrepid Potash | N/A | |
| Benjamin Pratt | The Mosaic | 57 | |
| James PEng | The Mosaic | 63 | |
Management Performance
| Return On Equity | 0.037 | ||||
| Return On Asset | 0.0293 |
Corteva Leadership Team
Elected by the shareholders, the Corteva's board of directors comprises two types of representatives: Corteva inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Corteva. The board's role is to monitor Corteva's management team and ensure that shareholders' interests are well served. Corteva's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Corteva's outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA BS, Executive CFO | ||
| Brian Titus, Principal Accounting Officer, Vice President Controller | ||
| Marcos Lutz, Independent Director | ||
| David Anderson, Chief Financial Officer, Executive Vice President | ||
| Patrick Ward, Independent Director | ||
| Cornel Fuerer, Senior Vice President General Counsel, Secretary | ||
| Sid Gorham, CEO Platform | ||
| Charles Magro, President, Chief Executive Officer, Director | ||
| Rebecca Liebert, Independent Director | ||
| Brook Cunningham, Senior Officer | ||
| Lois Juliber, Independent Director | ||
| Kerry Preete, Independent Director | ||
| Timothy Glenn, Executive Vice President Chief Commercial Officer | ||
| James Collins, Chief Executive Officer, Director | ||
| Gregory Friedman, Chief Financial Officer, Executive Vice President | ||
| Sam Eathington, Senior Vice President, Chief Technology Officer | ||
| Kimberly Booth, Vice Relations | ||
| Robert Brown, Independent Director | ||
| Lamberto Andreotti, Independent Director | ||
| Nayaki Nayyar, Independent Director | ||
| Lee Thomas, Independent Director | ||
| David Everitt, Independent Director | ||
| Gregory Page, Independent Chairman of the Board | ||
| Michael Johanns, Independent Director | ||
| MBA B, CEO Director | ||
| Robert King, Executive Vice President - Crop Protection Business Unit | ||
| Samuel Eathington, Executive Officer | ||
| Karen Grimes, Independent Director | ||
| Klaus Engel, Independent Director | ||
| Audrey Grimm, Chief VP | ||
| Janet Giesselman, Independent Director | ||
| Meghan Cassidy, Chief Human Resource Officer, Senior Vice President | ||
| BS MBA, Ex CFO | ||
| Rajan Gajaria, Executive Vice President - Business Platforms |
Corteva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Corteva a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.037 | ||||
| Return On Asset | 0.0293 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 39.21 B | ||||
| Shares Outstanding | 698.88 M | ||||
| Shares Owned By Insiders | 0.09 % | ||||
| Shares Owned By Institutions | 82.80 % | ||||
| Number Of Shares Shorted | 9.54 M | ||||
| Price To Earning | 29.88 X |
Pair Trading with Corteva
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Corteva position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corteva will appreciate offsetting losses from the drop in the long position's value.Moving together with Corteva Stock
| 0.67 | CF | CF Industries Holdings Earnings Call This Week | PairCorr |
| 0.74 | CGA | China Green Agriculture | PairCorr |
| 0.67 | ICL | ICL Israel Chemicals Financial Report 8th of May 2024 | PairCorr |
Moving against Corteva Stock
| 0.81 | IVP | Inspire Veterinary | PairCorr |
| 0.67 | LVRO | Lavoro Limited Class Fiscal Year End 6th of November 2024 | PairCorr |
| 0.65 | NITO | N2OFF Inc Symbol Change | PairCorr |
| 0.61 | BIOX | Bioceres Crop Solutions Financial Report 8th of May 2024 | PairCorr |
| 0.57 | X | United States Steel Earnings Call Tomorrow | PairCorr |
The ability to find closely correlated positions to Corteva could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Corteva when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Corteva - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Corteva to buy it.
The correlation of Corteva is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Corteva moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Corteva moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Corteva can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Corteva. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Corteva Stock refer to our How to Trade Corteva Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Corteva Stock analysis
When running Corteva's price analysis, check to measure Corteva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corteva is operating at the current time. Most of Corteva's value examination focuses on studying past and present price action to predict the probability of Corteva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corteva's price. Additionally, you may evaluate how the addition of Corteva to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Corteva's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Corteva. If investors know Corteva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Corteva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.25) | Dividend Share 0.63 | Earnings Share 1.3 | Revenue Per Share 24.296 | Quarterly Revenue Growth (0.03) |
The market value of Corteva is measured differently than its book value, which is the value of Corteva that is recorded on the company's balance sheet. Investors also form their own opinion of Corteva's value that differs from its market value or its book value, called intrinsic value, which is Corteva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Corteva's market value can be influenced by many factors that don't directly affect Corteva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Corteva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Corteva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Corteva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.